Novartis AG
https://www.novartis.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Novartis AG
Take Five: Ipsen Bags Rights To Day One Brain Cancer Drug
The Paris-based group has inked five external deals already this year, this time paying $111m to get access internationally to Day One Biopharmaceuticals' Ojemda for refractory pediatric low-grade glioma.
McKinsey Exec On Where India Innovation Could Head, Leveraging Pharma’s GCC Ecosystem
McKinsey & Company’s senior partner and lead, life sciences practice (Asia), talks to Scrip about innovation niches that could interest Indian firms including the ADC space, using AI to increase confidence in research activities and how India could leverage big pharma’s expanding global capability centres (GCCs) to shape the wider R&D ecosystem.
Stock Watch: Investor Reactions Diverge As J&J And Novartis Report Q2 Results
Both of the first two companies to report second-quarter financials maintained full-year sales guidance. But while Johnson & Johnson’s investors seemed cheered, Novartis’s may have been concerned about familiar issues.
Mounjaro Approval Takes Global Obesity Battle To China
The global battle of the blockbuster obesity drugs appears set to come to China with the approval of Lilly's Mounjaro, although domestic competitors are fast catching up.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Admune Therapeutics
- Amblyotech, Inc.
- Advanced Accelerator Applications SA (AAAP) (BioSynthema, Inc.)
- Aspen Japan K.K.
- Biocine
- CELLforCURE SASU
- Chiron Corporation
- CIBA-GEIGY
- Corthera Inc.
- CoStim Pharmaceuticals Inc.
- ESBATech AG
- Fougera Pharmaceuticals, Inc.
- Gyroscope Therapeutics Limited
- Hexal AG
- Lek Pharmaceuticals, Inc.
- Matrix Pharmaceuticals
- NeuTec Pharma
- Novartis Groupe France S.A.
- Novartis Pharmaceuticals
- Novartis Oncology
- Novogyne Pharmaceuticals (joint venture between Noven and Novartis)
- PowerVision, Inc.
- Protez Pharmaceuticals
- Sandoz Pharmaceuticals (Ever Neuro Pharma GmbH
- Ebewe Pharma)
- Selexys Pharmaceuticals Corporation
- Speedel Holding
- Spinifex Pharmaceuticals Pty. Ltd.
- Transcend Medical, Inc.
- Encore Vision, Inc.
- Ziarco Group Limited
- AveXis, Inc.
- BioLife Cell Bank, Inc.
- Endocyte, Inc.
- IFM Tre
- Zyma SA
- Annovation Biopharma, Inc.
- Boxford Subsidiary
- Curacyte Discovery GmbH
- Incline Therapeutics, Inc.
- ProFibrix B.V.
- Rempex Pharmaceuticals, Inc.
- Targanta Therapeutics Corporation
- Tenaxis Medical
- The Medicines Company
- Novartis Gene Therapies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice